YIH
NAMS icon

Y-Intercept (HK)’s NewAmsterdam Pharma NAMS Stock Holding History

Y-Intercept (HK)’s Portfolio NAMS Stock Details NAMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.65M Buy
+78,136
New +$2.57M 0.05% 543
2024
Q3 		– Sell
-14,607
Closed -$281K – 1626
2024
Q2 		$281K Sell
14,607
-11,601
-44% -$233K 0.02% 1049
2024
Q1 		$620K Buy
+26,208
New +$532K 0.05% 603

Other funds holding NAMS

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return

Y-Intercept (HK)'s NAMS Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in NewAmsterdam Pharma (NAMS) in Q2 2026: 78,136 shares worth $2.65M. The stake represents 0.05% of the portfolio and ranks #543 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in NAMS as recently as Q2 2024.

Y-Intercept (HK) first reported a position in NAMS in Q1 2024 and has held it in 3 quarters since. 194 funds tracked by Wall St. Rank hold NAMS as of Q2 2026.

  • Y-Intercept (HK) held 78,136 shares of NewAmsterdam Pharma worth $2.65M as of Q2 2026.
  • NewAmsterdam Pharma was a new Y-Intercept (HK) position in Q2 2026.
  • NewAmsterdam Pharma made up 0.05% of Y-Intercept (HK)'s portfolio in Q2 2026, its #543 holding.
  • Y-Intercept (HK) first reported a position in NewAmsterdam Pharma in Q1 2024 and has held it in 3 quarters since.
  • 194 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.